Treatment of a patient with a nodal peripheral T-cell lymphoma (angioimmunoblastic T-cell lymphoma) with a human monoclonal antibody against the CD4 antigen (HuMax-CD4)

Medical Oncology

Volumn 22, Issue 2, 2005, Pages 191-194

  Hagberg, H ^a   Pettersson, M ^a   Bjerner, T ^a   Enblad, G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angioimmunoblastic T cell lymphoma; Humax CD4; Peripheral T cell lymphoma

Indexed keywords

OKT 4;

AGED; ANEMIA; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TRANSFUSION; BREAST TENDERNESS; CANCER RECURRENCE; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DRUG EFFECT; GENERAL CONDITION DETERIORATION; GYNECOMASTIA; HUMAN; LEUKOCYTE COUNT; LYMPH NODE HYPERPLASIA; MALE; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PRURITUS; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; COMBINED MODALITY THERAPY; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOTHERAPY; LYMPH NODES; LYMPHOMA, T-CELL, PERIPHERAL; MALE; NEOPLASM RECURRENCE, LOCAL;

EID: 22344453419     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:22:2:191     Document Type: Article

References (9)

1. Dearden C, et al. High remission rate in T-cell prolymphocytic leukemia with Campath-1H. Blood 2001;98:1721-1726.
2. Lundin J, et al. Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome. Blood 2003;11:4267-4272.
3. Enblad G, et al. A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood 2004;8:2920-2924.
4. Skov L, et al. A fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. Arch Dermatol 2003;139:1433-1439.
5. Obitz ER, et al. HuMax-CD4, fully human monoclonal antibody: phase II trial in cutaneous T-cell lymphoma (CTCL). Abstract EORTC-meeting, Madrid, 2004.
6. Dogan A, Attygalle AD, Kyriakou C. Review: angioimmunoblastic T-cell lymphoma. Br J Haematol 2003;121:681-691.
7. Baum W, et al. Therapy with CD7 monoclonal antibody TH-69 is highly effective for xenografted human T-cell ALL. Br J Haematol 1996;95:327-338.
8. Peipp M, et al. A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T-cells. Cancer Res 2002;62:2848-2855.
9. Knox SJ, et al. Treatment of cutaneous T-cell lymphoma with a chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides. Blood 1996;87:893-899.